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The sigB operon of Bacillus subtilis encodes 7B and three additional open reading frames (orJV, orjW, and
orJX). Having previously mapped several mutations that alter the induction pattern of a fB-dependent
promoter (ctc) to regions of cloned B. subtilis DNA which contain these three open reading frames, we directly
tested the regulatory potential of orJV, orfW, and orJX by creating null alleles of each of these genes and
examining the effects of the mutations, either singly or in pairs, on transcription of ctc and the sigB operon.
Using lacZ reporter gene fusions and Northern (RNA) blot analyses, we have determined that all three genes
modulate the activation of the rB-dependent promoters at both the sigB operon and ctc. Our data are consistent
with the three gene products participating in a single pathway of negative control. orfW and orfX single-mutant
strains have high levels of sigB and ctc transcription. sigB and ctc transcription in an orfV strain is similar to
that found in mutant strains which lack (JB itself. The orfV mutation is dominant to oriX but recessive to o01W.
These results suggest that OrfW is the primary inhibitor of B-dependent transcription and that OrfV is
capable of counteracting the negative control of OrfW but is prevented from doing this by the orJX gene
product.
Bacillus subtilis contains at least nine different DNA-
dependent RNA polymerase holoenzymes. Each of these
enzymes carries a unique sigma subunit which endows it
with the capacity to recognize and initiate transcription at
distinct promoter sequences (14). Four of the sigma factors
(crE, cF, aG, and crK) are synthesized only when B. subtilis
undergoes sporulation (8, 10, 20, 23, 30, 31). They are
encoded by sporulation-essential genes dispensable to veg-
etatively growing bacteria (20, 23, 30, 32, 37). In addition to
sporulation-specific sigma factors, five sigma subunits have
been identified in vegetatively growing cells of B. subtilis
(13). orA is the most abundant of these proteins and is likely
to direct transcription of most of the "housekeeping" genes
that are expressed during vegetative growth. The remaining
four sigma factors (urB, aC, aD, and crH) are present at low
levels and constitute only a minor fraction of the total sigma
factor population present in vegetatively growing cells.
Physiological roles for two of the minor sigma factors have
been identified. CD directs the transcription of flagellar and
chemotaxis genes (14, 25), while aH is required for transcrip-
tion of competence and early sporulation genes (1, 5). The
functions of cB and crC are unknown, but given their minor
abundance (11, 12, 17), they are likely to participate in the
expression of highly specialized regulons. crc is known only
from its activity in in vitro transcription reactions (17). crB
has been analyzed both biochemically and genetically (3, 6,
12, 19). The gene encoding cB (sigB) was independently
cloned and sequenced by two laboratories (3, 6). These same
laboratories demonstrated by gene disruption experiments
that CrB is nonessential for both growth and sporulation (3, 6).
We have previously isolated and characterized mutations
which altered the expression of a CrB-dependent promoter
(ctc) (2, 34). During the course of our mapping studies, we
observed that two of our mutants mapped immediately
upstream of sigB (la). An analysis of the DNA sequence
surrounding the crB-coding region (sigB) by Kalman et al. led
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them to propose that sigB is the third gene of a four-gene
(orfV, orfW, sigB, and oriX) operon (19) and that the orfV
and orfW gene products might be important determinants of
orB activity due to significant homologies of the predicted
amino acid sequences of orlV and orJW to the spoIIAA and
spoIIAB gene products, respectively. spoIIAA and spoIIAB
are the upstream members of a three-gene operon (spoIIA)
which includes the structural gene for crF (spoIIAC) (9, 37).
Genetic evidence consistent with SpoIIAB being an inhibitor
of crF activity and SpoIIAA being an antagonist of this
inhibition has recently been presented (27, 29). Based on
homologies, similar roles were predicted for OrfV and OrfW
in the expression of aB-dependent genes (19).
In this paper, we describe an analysis of the role of the
orJV and orfW gene products in aB-dependent gene expres-
sion. Null mutations were constructed singly and in combi-
nation into each of the four reading frames of the sigB
operon. The effects of these mutations on the transcription
of both the orB-dependent promoter of the ctc gene and the
sigB operon itself were examined. The results of this study
support the notion that OrfV and OrfW control crB-depen-
dent transcription in a manner predicted by their homologies
to the cF regulatory proteins.
MATERIALS AND METHODS
Bacterial strains and culture media. Bacterial strains used
are listed in Table 1. All B. subtilis strains constructed for
this project were derived from PY22 that was originally
obtained from P. Youngman (University of Georgia). Esch-
erichia coli CJ236 was obtained from V. Deretic (The
University of Texas Health Science Center at San Antonio).
Luria broth (LB) and Difco sporulation medium (DSM) (28)
were prepared as previously described (18).
B. subtilis transformations. Plasmid and chromosomal
DNA was transformed into B. subtilis which had been made
competent by the method of Yasbin et al. (36). Transfor-
mants were selected on LB agar plates containing 5 ,ug of
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TABLE 1. List of strains and phage used
Strain or Relevant genotype Source or reference
phage
B. subtilis
PY22 trpC2 P. Youngman
BSA46 SP,B ctc::IacZ Made previously (2)
BSA67 or]X::pAK17 SP, ctc::IacZ This study
BSA69 aph3'5"/sigB314 SP1 ctc::lacZ This study
BSA70 aph3'5"1sigB SP1 ctc::lacZ This study
BSA73 aph3'5"1orflV312 SP,B ctc::lacZ This study
BSA74 sigB314 SP1 ctc::lacZ This study
BSA75 orfV312 SPP ctc::lacZ This study
BSA77 aph3'5"1orfV3l2 This study
BSA79 aph3'5"1orfW3J3 sigB314 SPP This study
ctc: :lacZ
BSA80 aph3'5"1sigB3I4 This study
BSA82 or]V312 orfX: :pAK17 SPP This study
ctc: :lacZ
BSA88 aph3'5"1orfW3l3 SP, This study
ctc: :lacZ
BSA91 aph3'5"/orfV312 or]W313 SP, This study
ctc: :IacZ
1A287 tmsAl trpC2 rpsL BGSCa
E. coli
CJ236 dut ung V. Deretic
JM103 dut+ ung+ V. Deretic
Phage
SPctc- c2del2::Tn917cat-1J::ctc-lacZ R. Losick (15)
lacZ
a BGSC, Bacillus Genetic Stock Center, The Ohio State University.
chloramphenicol per ml, 5 ,ug of kanamycin per ml, or 1 ,ug
of erythromycin per ml where appropriate.
B. subtlis congression. B. subtilis strains were transformed
with 100 ng of chromosomal DNA from strain 1A287 (tmsAl
trpC2 rpsL) and 2 ,ug of linearized plasmid vectors pB314 or
pV312. Transformants were selected on LB agar plates
containing 100 ,ug of streptomycin per ml and screened for
the absence of both ctc::lacZ expression and kanamycin
resistance. The presence of the unique EcoRI restriction
sites from the sigB314 and orfV312 alleles was confirmed by
Southern hybridization analysis, and the strains carrying
these alleles were designated BSA74 and BSA75, respec-
tively.
B. subtlis specialized transduction. Transductions with the
SP, phage which carries the ctc::lacZ translational fusion
(16, 38) were performed by adding 20 p.l of culture superna-
tant from a heat-shocked lysogen of PY16 to 1 ml of
logarithmically growing B. subtilis cultures. Transductants
were selected by being plated on LB agar containing 5 p,g of
chloramphenicol per ml or 1 jig of erythromycin per ml when
appropriate.
Mutagenesis. In order to study the effects of orfV, orJW,
and sigB mutations without interrupting the transcription
unit in which they reside, we chose to mutate each of these
genes by engineering frameshift mutations into their open
reading frames. Null mutations were constructed with
M13mpl8 (35) clones carrying orfV, orJW, and sigB on a
1.9-kb PstI fragment derived from pML7 (Fig. 1) (3). Muta-
genic oligonucleotides 312, 313, and 314 (Fig. 2) obtained
from the oligonucleotide synthesis facility at the University
of Texas Health Science Center at San Antonio were used to
insert two bases near the 5' ends of the coding regions of
orfV, orJW, or sigB to generate frameshift mutations and
create new EcoRI restriction sites. The presence of the
insertion mutations could thus be detected by the appear-
ance of a unique EcoRI restriction fragment in Southern
hybridizations. The oligonucleotides were hybridized in sep-
arate reactions to single-stranded recombinant M13mpl8
that had been passaged through CJ236 to incorporate uracil
into the template DNA. Synthesis of the second strand, with
Sequenase 2.0 (U.S. Biochemicals) and enrichment for mu-
tagenized templates, was performed by the method of
Kunkel (21), as previously described (18). Replicative form
DNA, prepared from progeny plaques, was screened for the
presence of the unique EcoRI restriction site characteristic
of a particular mutant allele. Positive clones were then
sequenced to confirm the presence of the engineered muta-
tion.
Construction of specialized plasmids and the delivery of the
orJV312, orJW313, and sigB314 afleles into the sigB operon. A
novel plasmid vector (pAK39) was developed for recombin-
ing the mutant orfV, orfW, and sigB alleles into the B.
subtilis chromosome. Figure 1 shows the plasmid construc-
tion. pML7 (3) carries a cloned B. subtilis DNA fragment
that extends from an EcoRI site approximately 1 kb up-
stream of the sigB operon to a SphI site approximately 2 kb
downstream of the operon (Fig. 1). DNA downstream of the
HindIII site within sigB was deleted from pML7 by being cut
with HindIll and SalI treated with S, nuclease and was
ligated to give plasmid pAK26. This left a unique EcoRV site
located approximately 500 bases upstream of the promoter
region of the sigB operon. Next, a 1.5-kb EcoRI-PstI frag-
ment from pAK21 (originally cloned as a ClaI fragment from
pJH1 [22]) containing a kanamycin resistance determinant
(aph3'5") was treated with S, nuclease and ligated into the
EcoRV site of pAK26 to give plasmid pAK33. This placed a
Kmr cassette approximately 500 bp upstream of the sigB
operon. The aph3'5" (Km9 transcription unit in pAK33 is
oriented such that it is transcribed divergently from the sigB
operon. Plasmid pAK33 was linearized at its unique ScaI site
and transformed into B. subtilis BSA46. Kanamycin-resis-
tant transformants in which the linearized plasmid DNA
carrying the intervening Kmr gene had undergone a double-
recombination event with its chromosomal homolog were
isolated. In order to ensure that the presence of the Kmr
gene at this location would not alter the expression of the
sigB operon or the crB-dependent ctc gene, a representative
transformant was chosen and tested for potential effects of
aph3'5" on sigB and ctc transcription. sigB operon-specific
RNA levels or the abundance of P-galactosidase derived
from ctc::lacZ reporter gene fusions were indistinguishable
between the strains that either carried or lacked the aph3'5"
gene upstream of the sigB operon (data not shown). Having
satisfied ourselves that the Kmr determinant was unlikely to
significantly alter sigB expression, we used this determinant
in the construction of plasmid vehicles which would transfer
the mutant sigB operon alleles into B. subtilis. An EcoRI-
PstI fragment of pAK33 was cloned into EcoRI-PstI-cut
pUC19 to give pAK39 (Fig. 1). pAK39 thereby contained the
unique PstI site upstream of the sigB operon at which the
1.9-kb PstI fragment from each of the mutant open reading
frames could be joined to reconstruct that segment of the B.
subtilis chromosome. Linearization of each of these plas-
mids (pV312, pW313, and pB314) with Scal, followed by its
transformation into B. subtilis, yielded kanamycin-resistant
transformants which had a high probability of carrying the
mutant alleles.
Southern hybridizations. Restriction endonuclease-di-
gested chromosomal DNA was fractionated in agarose gels
and transferred to nitrocellulose sheets by ascending chro-
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FIG. 1. Restriction endonuclease map of sigB operon DNA and the construction of pAK39, pV312, pW313, and pB314. The restriction
endonuclease map of chromosomal DNA present within pML7 redrawn from references 3 and 6 is shown at the top of the figure. The thick
lines represent the sigB open reading frames (6, 19), and the arrow designates a putative transcriptional start site (19). Plasmid constructions
are described in detail in Results. The Kmr gene (aph3'5") used in the construction of pAK39 was originally obtained as a ClaI fragment from
pJH1 (22). Abbreviations: C, ClaI; E, EcoRI; H, Hindlll; P, PstI; S, SpeI; V, EcoRV; S', Sall; V312, orfV312; W313, orfW313; B314,
sigB314.
matography. Hybridizations to nick-translated probes de-
rived from the 2.3-kb EcoRI fragment of pML7 (3) were
performed overnight at 37°C in 5x SSC (lx SSC is 0.15 M
sodium chloride plus 0.015 M sodium citrate [pH 7.4])-50%
formamide-0.1% SDS- x Denhardt's solution (4). Hybrid-
ized fragments were detected by autoradiography.
Northern (RNA) blot analysis. RNA was prepared from
mid-log- and stationary-phase cultures by standard methods
(34) and stored at -70°C as an ethanol precipitate. Two
hundred micrograms of each sample was fractionated by
electrophoresis on a 1% agarose gel containing 0.6 M form-
aldehyde. RNA was transferred to nitrocellulose sheets by
ascending chromatography in lOx SSC. Nitrocellulose-
bound RNA was incubated for 4 h at 37°C in 5x SSC-0.1%
sodium dodecyl sulfate (SDS)-1 x Denhardt's solution (4)-10
p,g of calf thymus DNA per ml-50% formamide and then
hybridized to a single-stranded DNA probe overnight under
the same conditions. Single-stranded probes were prepared
from an M13mpl8 template carrying the coding strand of a
1.9-kb PstI fragment of the sigB operon by using an oligo-
nucleotide (ATAAGGCTTGATAGC) complementary to this
strand at a site immediately downstream of the EcoRI site in
sigB (Fig. 1) as a primer. Briefly, 500 pg of single-stranded
template was annealed to 20 ng of oligonucleotide, and then
3 U of Sequenase (U.S. Biochemicals) and 125 fmol of
32P-labeled dATP, dTTP, dGTP, and dGTP were added. The
labeling reaction was continued for 5 min at room tempera-
ture, 10 pmol of unlabeled dNTP was then added, and the
P Sphl
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M N I N V D V K
orfV. AGGTGATACGAATGAAT ATAAATGTTGATGTGAAG.
312 ACTATGCTTACTTAAGTAT TTACAACTACA
M N S ***
orfV.... AGGTGATACGAATGAATTCATAAATGTTGATGT GAAG.
312 EcoRl
B
M K N N A D Y I E M K
orfW. GCAAT GAAGAAT AAT GCT GATT ACAT CGAAAT GAAG.
313 TACTTCTT AAGTTACGACTAATGTA
M K N S M V I T S K *
orfW....GCAAT GAAGAATTCAAT GCT GATT ACATC GAAAT GAAA..........
313 Eco RI
C
...T K D E V D R L I S D
sigB. ACTAAAGATGAAGTCGA TCGGCTCATAAGCGAT.
314 TTCTACTTCAGCTTAAGCCGAGTATTCG
...T K D E V D F G S ***
sigB....ACTAAAGAT GAAGT C GAA TTC GGC T C AT AAGC GAT...........
314 E
FIG. 2. Structure of oligonucleotide-directed mutations introduced into the open reading frames of the sigB operon. The top nucleotide
sequence in each group (A, B, or C) represents the coding sequence (19) for a portion of the indicated wild-type gene (orfV, orfW, or sigB).
Immediately above it is the single-letter amino acid sequence predicted from the nucleotide sequence. Immediately below the sequence is the
mutagenic oligonucleotide used to generate the indicated allele (e.g., orfV312). The second nucleotide sequence in each group represents the
sequence of the mutant allele with the predicted amino acid sequence of its product illustrated above it. The *** depicts a termination codon
introduced by the mutation, while the underlined sequence indicates the position of an allele-specific EcoRI restriction endonuclease site also
generated by the mutation. The orfV312, orfV313, and sigB314 genes have termination codons at positions 4, 11, and 22, respectively.
mixture was further incubated for 5 min. Incorporated label
was then ethanol precipitated.
Dot blot analysis of RNA. RNA samples prepared as
described above for the Northern blot analysis were diluted
in 0.3 M NaCl-30 mM trisodium citrate (pH 7.0) and spotted
in 2-,ul volumes onto nitrocellulose. The resulting filters were
baked and blocked as previously described (34). The filters
were then incubated overnight at 37°C in 5x SSC-0.1%
SDS-10 ,ug of calf thymus DNA per ml-lx Denhart's
solution (4)-50% formamide with the single-stranded DNA
probe used in the Northern blot analysis. Bound probe was
visualized by autoradiography.
,l-Galactosidase assays. Cells were harvested from cultures
and frozen at -70°C until further use. P-Galactosidase
activity was detected in lysates prepared by resuspending
cell pellets in 5 ml of Z buffer (24) and passaging the cells
through a French pressure cell at 15,000 lb/in2. Debris was
removed by centrifugation at 10,000 x g for 10 min. Dilu-
tions of the supernatants were assayed for P-galactosidase
activity by the method of Miller (24). The amount of protein
present in the extracts was quantitated by using the Bio-Rad
protein assay reagent as recommended by the manufacturer.
13-Galactosidase activity was calculated as the optical den-
sity at 420 nm x 100 per milligram of protein.
RESULTS
Both sigB and orfV are required to activate ctc::lacZ tran-
scription. To evaluate the efficiency with which the plasmids
that carried sigB operon mutations could deliver the mutant
alleles as replacements for their chromosomal homologs, we
first sought to construct the sigB null mutant as a test of the
system. Since expression of the ctc::IacZ translational fu-
sion present within SP,B ctc-lacZ is known to be dependent
on uB (16), a sigB null mutation would confer an easily
scoreable Lac- phenotype on strains which carry this phage.
Plasmid pB314 (sigB314) was linearized at its unique ScaI
site and introduced into competent cells of strain BSA46
(PY22 [SPPictc::lacZ]) by transformation. Kanamycin-resis-
tant transformants were then patched onto LB agar plates
containing 5% glucose, 0.2% glutamine, and X-Gal (5-
bromo-4-chloro-3-indolyl-p-D-galactopyranoside) (15). Of
153 Kmr colonies, 53 (38%) were white on this medium,
indicating that they had lost the ability to synthesize ,-ga-
lactosidase from the ctc::lacZ fusion. The chromosomal
DNA of five of the white colonies was digested with EcoRI
and analyzed by Southern hybridization with a sigB operon-
specific probe. All five had restriction patterns consistent
with the presence of both the kanamycin resistance gene and
the EcoRI site which identifies the sigB314 allele (data not
shown). One of the strains carrying the sigB314 allele
(BSA69) was grown in liquid medium and analyzed for
ctc::lacZ expression (Fig. 3A). BSA69 failed to induce the
ctc promoter, while an isogenic wild-type strain (BSA70)
displayed a clear induction of ctc. These results both confirm
that ctc induction in SPP ctc-lacZ is dependent on aB and
demonstrate that cotransformation with the selectable kana-
mycin resistance gene is an efficient means of transferring
the sigB mutant alleles into B. subtilis.
We next transferred the orfV312 mutation into B. subtilis
to determine its effect on the B-dependent induction of ctc.
Plasmid pV312 was linearized at the unique ScaI site and
introduced into BSA46 by transformation. Of 80 Kmr colo-
nies, 63 (78.7%) were Lac- on LB (with glucose and
glutamine) plates containing X-Gal. Chromosomal DNA
from both Lac- and Lac' transformants was screened by
Southern hybridization for the EcoRI digestion pattern that
is characteristic of the orfV312 allele. The restriction endo-
nuclease pattern expected of strains which carried the
orfV312 allele was found among only the Lac transfor-
J. BACTERIOL.
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FIG. 3. Effects of mutations within orfV, orfW, and sigB on
expression of the ctc::lacZ fusion. Cells were grown in either LB
supplemented with 5% glucose and 0.2% glutamine (circles) or DSM
(squares), harvested, and analyzed for ,3-galactosidase activity, as
described in Materials and Methods. Stationary phase occurred
between 2.5 and 3 h postinoculation for strains BSA69 (sigB314),
BSA70 (wild type), and BSA73 (orfV312), while BSA88 (orfW313)
and BSA91 (orfV312, orJW313) entered stationary phase between
4.5 and 5 h after inoculation. (A) BSA70 (0) and BSA69 (0) grown
in LB; (B) BSA70 grown in LB () or DSM (U) and BSA73 grown
in LB (0) or DSM (O); (C) BSA70 grown in LB (0) or DSM (U) and
BSA88 grown in LB (0) or DSM (O); (D) BSA91 grown in LB (0)
or DSM (O) and BSA88 grown in LB (0) or DSM (U).
mants (data not shown). One transformant carrying the
orfV312 allele (BSA73) was grown in liquid medium and
analyzed for ctc expression (Fig. 3B). Virtually no P-galac-
tosidase activity was measured from the ctc::lacZ fusion
when the mutant culture was grown in either LB (with
glucose and glutamine) or DSM. Thus, ctc transcription
requires the orfV gene product as well as (JB. This suggests
either that the V product is required for CrB synthesis or that
it is a positive effector necessary for aB-dependent transcrip-
tion at ctc.
orJW product inhibits ctc transcription. The orfW homolog,
spoIIAB, encodes a negative regulator of uF-dependent
transcription (29). A null allele of spoIIAB is detrimental to
cell survival, and strains which carry mutations within the aF
coding region (spoIIAC) rapidly appear in this background
(29). Given the similarities between the spoIIA and sigB
operons, it seemed likely that the orfW313 allele might also
be deleterious to cell survival in a sigB+ background. We
therefore designed a transformation experiment which
would take this potential obstacle into account. A sigB314
strain (BSA74) was used as a recipient for the initial transfer
of orfW313 into B. subtilis. Since pW313 carries both a
wild-type orfV and sigB allele in addition to orfW313, it is
possible that both orfW313 sigB+ and or]W313 sigB314
transformants could be created as a result of the transfor-
mation. After incubation of competent BSA74 with Scal-
linearized pW313, the transformants were plated onto LB
agar plates containing 5 pLg of kanamycin per ml, 5% glucose,
0.2% glutamine, and X-Gal. Two colony types were distin-
guishable on this medium. A majority of the colonies (125 of
180) were very small and substantially darker blue than those
from a sigB+ orfW+ control strain (BSA46). The remaining
55 formed normal-sized white colonies. Three of the former
class and six of the latter class were chosen for genotypic
analysis by Southern hybridization. The resulting patterns
(data not shown) revealed that the slowly growing, dark blue
colonies had inherited both the orJW313 and the sigB+
alleles along with the kanamycin cassette from pW313. All of
the white colonies that we screened had retained the sigB314
allele and either carried only the kanamycin resistance
determinant or carried both the kanamycin cassette and the
orfW313 allele. The orfW313 allele in the presence of a sigB+
allele, therefore, results in enhanced transcription from the
ctc promoter and an inhibition of normal cell growth. The
orfW313 sigB+ strains also displayed an oligosporogenous
phenotype, as evidenced by their failure to turn brown on
DSM plates. Thus, there is a direct parallel between orfW
and its counterpart in the spoIIA operon; both orfW and
spoIIAB negatively regulate transcription that depends on
their corresponding sigma factors, and the toxicity of null
mutations in each allele appears to be alleviated by a null
mutation within the sigma factor with which it is cotrans-
cribed.
Quantitating the orfW defect in a strain (BSA88) which
carried it proved to be difficult because of its slow growth
rate and the rapid appearance and overgrowth of suppressor
mutants which have acquired more-normal growth rates. We
circumvented this problem by slowing the growth rate of the
inoculum cultures to minimize the growth advantage of the
suppressor strains. This involved incubating the overnight
inoculum in liquid medium, with very slow shaking. This
procedure evolved from the observation that overnight
BSA88 cultures that were rapidly shaken invariably con-
tained only a small proportion of cells which displayed the
orfW313 phenotype when plated, while slowly shaken
BSA88 cultures often contained mostly OrfW- cells. Per-
haps the metabolism of BSA88 is so compromised by the
or]W313 defect that lower levels of aeration are not limiting
to its already slow growth rate as they would be to that of a
wild-type strain. Regardless of the basis for this phenome-
non, it provided us with a means of obtaining OrfW-
cultures for analysis. BSA88 cultures were routinely plated
to estimate the percentage of cells which still displayed the
orfW313 colony morphology, and only those cultures that
gave rise to greater than 90% OrfW- colonies were used for
analysis. The effect of the orfW313 allele on ctc expression is
illustrated in Fig. 3C. The ctc promoter in strain BSA88 was
active throughout growth and stationary phase at levels
nearly fivefold higher than those in the isogenic wild-type
strain BSA70. We conclude that orfW encodes a protein
which either directly or indirectly inhibits ctc transcription.
Although the ctc-dependent ,B-galactosidase levels were el-
evated in both LB and DSM, ctc transcription was higher in
LB than it was in DSM. This is the same medium-specific
effect seen with the wild-type strain. It would, therefore,
appear that the medium-dependent modulation of ctc expres-
sion is not likely to be controlled by means of the orfW gene
product.
The OrfV antagonizes OrfW activity. Having shown that
the orfV gene product was necessary for ctc expression in an
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orJW+ background, we next tested its role in the absence of
OrtW. This required construction of a strain carrying both
the orfV312 and orfW313 alleles. A DNA fragment contain-
ing both mutant alleles was generated by mutagenizing
single-strand templates of the M13 clone which contained
the orfV312 mutation with the orJW313-generating oligonu-
cleotide. The PstI fragment (Fig. 1) from a clone containing
both the orfV312 and orJW313 mutations was then ligated to
pAK39 to create pVW312/313. An orjV312-containing strain
(BSA75), constructed by congression of the orfV312 allele
into BSA46, was used as a recipient in a transformation
experiment with Scal-linearized pVW312/313. The transfor-
mants were plated onto LB agar containing 5 ,g of kanamy-
cin per ml, 5% glucose, 0.2% glutamine, and X-Gal. Of 86
transformants which arose from this experiment, 52 (60%)
grew poorly and turned dark blue, while the remaining 34
grew as normal-sized colonies and remained white. Since the
recipient strain in this experiment carried the orfV312 allele,
and the transforming DNA also contained the orfV312 se-
quence as well as the orfW313 allele, all of the transfor-
mants, including those which mimic the orfW313 phenotype,
must carry the or]fV312 mutation. This result indicates that
the OrfV protein is nonessential for the high-level expression
of ctc in the absence of OrfW. The normal-sized white
colonies (OrfV-) presumably had acquired only the aph3'5"
gene and not the orfW313 allele. The genotypes were con-
firmed by Southern hybridization analysis of chromosomal
DNAs from three dark blue colonies and six white colonies
(data not shown). The sizes of the hybridizing EcoRI frag-
ments from the chromosomes of these transformants were
consistent with the poorly growing, dark blue colonies
carrying both the orfV312 and the ortW313 alleles along with
the kanamycin resistance determinant, while the larger,
white colonies contained only the aph3'5" gene and were
orfV312 orfW+.
To more precisely compare the effects of the orfV312
orjW313 mutations on ctc transcription, one of the double-
mutant transformants (BSA91) was grown in DSM or LB
(supplemented with 5% glucose and 0.2% glutamine) and
analyzed for p-galactosidase expression from the ctc::lacZ
translational fusion. The results, shown in Fig. 3D, demon-
strate that ctc expression in BSA91 (orfV312 orJW313) is
nearly identical to that of BSA88 (orfW313). Thus, the orfW
null mutation is dominant over the orfV312 mutation. This is
consistent with the notion, proposed from the spoIIA data,
that the orfV product would be an antagonist of orfW.
Apparently, the need for orfV in ctc expression is limited to
a requirement to counteract the effects of orfW.
orfX influences sigB and ck transcription through the orfV
regulator. Previously, Igo et al. (15) had shown that null
mutations within orJX led to heightened transcription of ctc
and inhibition of cell growth. The basis of this phenotype is
thought to be elevated cB levels, which occur as a conse-
quence of a derepression of the sigB operon in the orfX
strains (15, 19). The data above demonstrate that ctc tran-
scription in a wild-type strain is dependent on the orfV gene
product. Because of the similarity of the orfX and or]W313
phenotypes at the ctc promoter, we were prompted to ask
whether orfV was essential for ctc induction in an oriX
background.
To examine this question, ctc::lacZ expression was mon-
itored in an orJV312 or]X::pAK17 mutant (BSA82). This
strain was constructed by first introducing the orfV312 allele
into PY22 by a gene replacement to create strain BSA77 and
then transforming this strain with plasmid pAK17. pAK17
was derived from the integrating vector pJM102 (18) by
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FIG. 4. Effect of orfV and orJX on ctc transcription. Strains
BSA67 (orJX::pAK17) (U), BSA73 (orfV312) (O), and BSA82
(orfV312, orfX::pAK17) (X) which carry SP3 ctc::IacZ were grown
in LB (with 5% glucose and 0.2% glutamine). Cells were harvested
and analyzed for ,B-galactosidase as described for Fig. 3. Stationary
phase began at approximately hour 3 for BSA73 and BSA82 and at
hour 4.5 for BSA67.
cloning a 700-bp EcoRV fragment encompassing the 3' end
of sigB and the 5' end of orfX into its unique SmaI site.
Integration of pAK17 into a recipient cell's chromosome at
the sigB-orjX junction produces chloramphenicol-resistant
transformants, which contain a truncated copy of orfX under
the control of its normal promoter and an intact, untran-
scribed copy of orfX downstream of the vector sequence
(la). When introduced into an isogenic wild-type strain
(BSA70), pAK17 produces small colonies which overex-
press ctc. However, transformation of BSA77 (orfV312) by
pAK17 produced only normal-sized colonies, suggesting that
orJV was essential for ctc synthesis in an orfX::pAK17
background. To quantitate this effect, we transduced the
ctc: :lacZ fusion on SPP into the orfV312 orfX: :pAK17
strain, selecting for erythromycin resistance, to produce
strain BSA82. When BSA82 was grown in either LB (with
glucose and glutamine) or DSM (Fig. 4), it displayed the
orfV312 phenotype of failing to induce the ctc promoter.
Based on these data, the orjX phenotype of growth inhibition
and ctc expression is dependent on the orfV gene product.
This is consistent with the notion that the deleterious effect
of an orfX allele is due to enhanced cr activity but, in the
absence of or]V, crB fails to be synthesized or is not active
regardless of the state of orfX.
Analysis of sigB transcription. Both ctc and the sigB
operon are transcribed by E-aoB (16, 19). Thus, the influence
of the orfV312 and orfW313 mutations on ctc expression may
be the result of a direct effect on crB-dependent transcription
at ctc, or an indirect effect, due to changes in crB levels
brought about by changes in the transcription of the sigB
operon or both. In order to determine if the orfW and or]V
mutations were affecting sigB expression, we examined the
relative abundance of sigB-specific RNA in these strains. As
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FIG. 5. Comparison of sigB-specific RNA levels ii
mutant B. subtilis strains. Dilutions of RNA extract
ary-phase cells that had been grown in either LB (w
and 0.2% glutamine) or DSM were spotted onto niti
hybridized to the single-stranded DNA probe. Eith
12.5 -y of RNA from strains BSA70 (wild type), BS
BSA69 (sigB314), BSA76 (orfV312 orjX::Km) and E
or]X::Km9) or 10, 5, and 2.5 -y of RNA from BSA88
BSA64 (orfX::Km9 were used. The binding of the lab
visualized by autoradiography with an exposure timi
a preliminary experiment, we performed a ID
analysis by using the antisense sequence of th
sigB region (Materials and Methods) as a prn
shown). Kalman et al. (19) observed an RNA of
they concluded initiated from a cB-dependent
bp upstream of orfV and terminated 43 bp down
orfX termination codon. Our wild-type strain
tained a prominent RNA of approximately
minor transcript of 2.7 kb which reacted M
operon probe. The 2.5-kb RNA was markedly
an orJW313 strain and absent from orfV31L
strains. The 2.7-kb transcript was unaffected by
sigB or the orfV-orfW system. We found, as d
al. (19), that the cB-dependent sigB promote
both DSM and LB.
RNA was extracted from wild-type and mutz
that had entered stationary phase in mediur
permitted (LB-glucose-glutamine) or inhibite
induction of the aB-dependent ctc promoter
were spotted onto nitrocellulose and hybridi
same 32P-labeled, sigB-specific probe that wa
Northern blot analysis. An autoradiogram of
labeled RNA spots is displayed in Fig. 5. 1
strain (BSA70) contained significantly more
RNA than did strains with null mutations in orf
sigB (BSA69). This is consistent with the D
results which indicated that the bulk of sigB tr
aB-dependent and that this transcription requ
product. Likewise, inactivation of orJW (BS.
(BSA64) resulted in an approximately 10-fol
sigB RNA over that seen with the wild-typ
enhanced transcription of sigB that is observed
strain is crB-dependent and subject to orfV-,c
10 5 2.5 Mutations in either sigB (BSA92) or orfV (BSA76) totally
mask the effect of the null mutation in orfX. The results of
- this analysis are a direct parallel to the observed effects of
the same mutations at the ctc promoter. In both cases, orIW
and orfX mutations resulted in high-level expression that
was substantially reduced by mutations in sigB.
- DISCUSSION
We had previously isolated mutations which increased
transcription from the uB-dependent ctc promoter (34). The
majority of these mutations mapped to the sigB operon
within the previously described orfX region, while others
mapped to a fragment spanning the orfV-orJW open reading
frames (la). We have now shown that orfV and ortW are
important regulators of cu activity. The ctc gene and the
sigB operon are predominantly expressed from (rB-depen-
dent promoters under the medium conditions that we em-
ployed. The orfV product is essential for the activity of these
promoters. In its absence, transcription of both ctc and the
sigB operon falls to a level that is equal to that seen with a
n wild-type and sigB314 strain. The orfW protein, on the other hand, has the
Is from station- characteristics of an inhibitor of ctc and sigB transcription.
'ith 5% glucose In its absence, crB-dependent sigB and ctc transcription is
rocellulose and markedly increased. The high level of ctc expression that is
er 50, 25, and seen with the orfW strain is not inhibited by the loss of the
A73 (orfV312), orfV gene product. In the absence of orfW, orfV is dispens-
ISA92 (sigB314 able. The simplest interpretation of this result is that the orfV
e(orob313) and product is essential for the activity of the crB-dependent
e of 24 h. promoters by virtue of its ability to counteract the negativeeffects of the ortW gene product. These findings are similar
to those observed by Price and his associates, who per-
formed a deletion analysis of the sigB operon (3a).
4orthern blot OrfX had previously been shown to be a negative regula-
ie orfV-orfW- tor of sigB expression (15, 19). We have verified this result
)be (data not and have determined that the negative regulation due to orJX
f2.5 kb which is subordinate to that provided by or.fW; when orfW is
tpromoter 32 absent, or,X does not appear to be capable of inhibiting sigB
istream of the expression. The negative effects of orfX and ortW occur at
(BSA70) con- the uB-dependent promoter of sigB and not at this operon's
2.5 kb and a g'-independent promoter. We saw no indication that the
vith the sigB upstream cB-independent promoter was more active in an
( increased in or]X::pAK17 or orfW313 strain. Thus, the orfX and orfW
2 or sigB314 proteins either specifically affect the sigB operon's CrB_
y mutations in dependent promoter or, alternatively, affect the activity of
lid Kalman et the urB-containing holoenzyme itself.
r is active in Two models consistent with aspects of our current data
are presented in Fig. 6. Model A illustrates a hypothetical
ant B. subtilis control mechanism in which oriX and orfW gene products
m that either act independently to inhibit the sigB operon's uB-dependent
d (DSM) the promoter. Independent inhibition by each of these gene
*. The RNAs products would explain why orfV would still be needed to
ized with the modulate OrfW in an orfX::pAK17 strain. Our current data
Ls used in the fail to distinguish between inhibition occurring specifically at
the resulting the uB-dependent sigB promoter or at the level of forming an
Phe wild-type active E_CrB. The essential feature of model A is that orfX
sigB-specific and orJW are unconnected in their control of the sigB
V (BSA73) or operon, but cumulatively, they modulate the effectiveness of
4orthern blot the sigB promoter or the activity of E_UB. The notion that
anscription is OrfW and OrfX are independent regulators is not, however,
iires the orfV easily reconciled with the observation that the sigB operon's
A88) or orfX uB-dependent promoter is used at a very high level in an
d increase in orfX::pAK17 orJW+ orfV+ strain (Fig. 5). It would be
e strain. The expected that if the orfW gene product was independent of
with the orfX OrfX, it would continue to inhibit sigB transcription.
nrfW control. Clearly, the potential for OrfW inhibition exists in the
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FIG. 6. Models for OrfV, OrfW, and OrfX control of sigB. (A)
OrfX and OrfW are independent inhibitors of ac3 activity, as specific
inhibitors of either PB function (labeled 1) or the activity of aB-
containing RNA polymerase (E-_B) (labeled 2); (B) OrfX, OrfV and
OrfW are members of a common pathway which either directly
regulates PB (labeled 1) or controls the activity of E-_B (labeled 2).
OrfW is the effector of inhibition. Its activity is blocked by OrfV,
which is, in turn, negatively regulated by OrfX.
orfX::pAK17 strain because high-level transcription of sigB
in the orJX::pAK17 background still requires orfV (i.e.,
transcription of sigB is severely inhibited in an orJX: :pAK17
orfV312 strain (Fig. 5) presumably because of a failure to
modulate the activity of OrfW). It is possible that factors yet
to be identified enhance the ability of OrfV to counteract
OrfW in the orlX::pAK17 strain; however, an alternative
model (Fig. 6B) can take this result into account without the
need for additional unknown factors. Instead of the hypoth-
esis of independent OrfX and OrfV-OrfW control, OrfX
could be viewed as a component of the OrfV-OrfW control
system. Specifically, OrfX might function as a negative
regulator of OrfV. By this model, OrfV would be predicted
to have the inherent capacity to counteract the inhibitory
effects of OrfW but is prevented from doing this by OrfX.
Thus, OrfW could be viewed as the terminal inhibitory
molecule. If OrfW is lacking, inhibition of sigB is removed
regardless of the status of OrfV or OrfX. If OrfW is present,
OrfV is needed for release from OrfW inhibition regardless
of the state of OrfX. This is consistent with the finding that
an orfV orfX::pAK17 strain is not inducible. We speculate
that in the absence of OrfX, OrfV is not restrained in its
ability to counteract OrfW. This would explain why the sigB
operon is induced in an orfX: :pAK17 strain to approximately
the same extent as it is in an or]W313 strain (Fig. 5). We are
currently testing these models by genetic and biochemical
means.
Kalman et al. (19) have documented the high degree of
homology between spoIIAA-spoIIAB and orfV-orJW. Not
only are the protein products of these genes homologous but
also their coding sequences are configured in a similar
manner. The termination codons of spoIIAA and orfV over-
lap the initiation codons of spoJIAB and oriW, respectively,
with identical sequences at the junctions of each (9, 19). This
overlap has been suggested to be an indication that the
products of each gene pair may be translationally coupled (9,
19). Experimental support for translational coupling in the
spoIIA system comes from the observation that a mutation
in the ribosomal binding site of spoIIAA significantly reduces
the expression of a downstream spolIAB::IacZ translational
fusion and confers on the strains which carry it the pheno-
type expected of a strain deficient in both spoIIAA and
spoIIAB (26). A similar loss of the activity of the down-
stream member of the regulatory pair due to disrupting
translation of the upstream member was not seen in our
study of the sigB operon. The phenotype of the frameshift-
termination mutation in orfV was the opposite of the pheno-
type conferred by mutations in both orJV and oriW. The
reason for this difference in translational polarity between
these two superficially similar operons must await further
experimentation.
It is unclear from the data presented in this paper whether
the orfV and orfW proteins only affect transcription from the
aB-dependent promoter of the sigB operon or additional
promoters that are recognized by E-aB. The mutations in
orfV, orfW, and orfX had identical effects on the activity of
both the aB-dependent sigB and ctc promoters; however, the
effect of the mutations on ctc transcription could be indirect,
that is, a consequence of their influence on sigB expression
and the resulting changes in or levels. The notion that or]V
and orfW are not limited to only regulating E-crB activity at
the sigB promoter is suggested by studies of the homologous
proteins SpoIIAA and SpoIIAB. Genetic experiments have
recently shown that SpoIIAB is an inhibitor of cF-containing
RNA polymerase and that SpoIIAA antagonizes the inhibi-
tory activity of SpoIIAB (29). Interestingly, a mutant aF,
which was capable of recognizing a promoter normally
recognized exclusively by another sigma factor (aG), re-
mained sensitive to control by SpoIIAA and SpoIIAB in
transcribing from that previously unrelated promoter (29).
These findings were interpreted as evidence that SpoIIAA
and SpoIlAB function at the level of E-aF activity and not at
the level of a particular promoter sequence (29). Kalman et
al. (19) have documented the high degree of homology
between spoIIAA-spoIIAB and orfV-orfW, and in this paper,
we have demonstrated their functional similarities. It would,
therefore, not be surprising if OrfW, like SpoIIAB, was a
general inhibitor of the activity of its associated a factor. In
support of this idea, we have recently observed that the
orfW313 allele yields high levels of ctc transcription and
impairs growth in a mutant strain in which the cB-dependent
promoter element of sigB has been replaced by the cr-
independent SPAC promoter (la). Presumably, the or]W313
allele is permitting E_aB to function at an inappropriately
high level. If this is true, then the negative regulation of
JrB-dependent transcription by orfV-orfW directly parallels
the negative regulation of uF-dependent transcription by the
spoIIAA-spoIIAB system. It is tempting to speculate that the
regulatory pairs of the orfV-orfW class may represent a
common device for controlling the activity of some second-
ary sigma factors.
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